• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非侵入性监测左心室舒张末期压可降低心力衰竭住院患者的再住院率:一项随机对照试验。

Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial.

机构信息

VA Boston Healthcare System, Boston, Massachusetts 02132, USA.

出版信息

J Card Fail. 2011 Sep;17(9):718-25. doi: 10.1016/j.cardfail.2011.04.014.

DOI:10.1016/j.cardfail.2011.04.014
PMID:21872140
Abstract

BACKGROUND

In patients admitted for heart failure (HF), unrecognized elevation of left ventricular end-diastolic pressure (LVEDP) at the time of discharge may have a role in the high rehospitalization rate for HF on follow-up.

METHODS AND RESULTS

In a small, prospective study (n = 50), patients admitted for HF were randomized to management guided by daily noninvasive estimated LVEDP monitoring (Group I, open) to a target LVEDP of <20 mm Hg or management based on clinical assessment alone without knowledge of the estimated LVEDP (Group II, blinded). Noninvasive estimated LVEDP was measured by the VeriCor monitor, which uses the Valsalva maneuver to derive the LVEDP. The primary endpoints were the reduction of estimated LVEDP at discharge and the HF rehospitalization rate on follow-up. Estimated LVEDP was significantly reduced at discharge in the open group compared with the blinded group (mean estimated LVEDP 19.7 ± 1.3 mm Hg vs 25.6 ± 1.5 mm Hg, respectively, P = 0.01). The rehospitalization rates for HF on follow-up were significantly improved in the open group compared with the blinded group (at 1 month: 0% vs 25%, respectively [P = .05]; at 3 months: 0% vs 32% [P = .01]; at 6 months: 4% vs 36% [P = .01]; at 1 year: 16% vs 48% [P = .03]).

CONCLUSIONS

When HF is managed by clinical assessment only, estimated LVEDPs remain high at discharge, resulting in early and frequent rehospitalization for HF. Therapy guided by estimated LVEDP monitoring optimizes filling pressures and reduces HF rehospitalization rates.

摘要

背景

在因心力衰竭(HF)住院的患者中,出院时未识别的左心室舒张末期压(LVEDP)升高可能是 HF 患者在随访中再住院率高的原因。

方法和结果

在一项小型前瞻性研究中(n=50),因 HF 入院的患者被随机分为两组:一组接受每日非侵入性估计的 LVEDP 监测指导的治疗(I 组,开放组),目标 LVEDP<20mmHg;另一组接受单纯临床评估指导的治疗(II 组,盲法组),不了解估计的 LVEDP。非侵入性估计的 LVEDP 通过 VeriCor 监测仪测量,该监测仪使用瓦尔萨尔瓦动作来推导 LVEDP。主要终点是出院时估计的 LVEDP 降低和 HF 再住院率。与盲法组相比,开放组出院时估计的 LVEDP 显著降低(平均估计 LVEDP 分别为 19.7±1.3mmHg 和 25.6±1.5mmHg,P=0.01)。与盲法组相比,开放组 HF 的再住院率在随访中显著改善(1 个月时:0% vs 25%,分别为 [P=0.05];3 个月时:0% vs 32%,分别为 [P=0.01];6 个月时:4% vs 36%,分别为 [P=0.01];1 年时:16% vs 48%,分别为 [P=0.03])。

结论

当 HF 仅通过临床评估进行管理时,LVEDP 在出院时仍较高,导致 HF 早期和频繁再住院。通过估计的 LVEDP 监测指导的治疗可以优化充盈压并降低 HF 再住院率。

相似文献

1
Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial.非侵入性监测左心室舒张末期压可降低心力衰竭住院患者的再住院率:一项随机对照试验。
J Card Fail. 2011 Sep;17(9):718-25. doi: 10.1016/j.cardfail.2011.04.014.
2
Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.对心力衰竭患者进行胸腔内阻抗和右心室压力的连续监测。
Circ Heart Fail. 2010 May;3(3):370-7. doi: 10.1161/CIRCHEARTFAILURE.109.867549. Epub 2010 Mar 2.
3
Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.充血性心力衰竭合并孤立性左心室舒张功能障碍患者的患病率、临床特征、生活质量及预后
J Am Soc Echocardiogr. 2004 Mar;17(3):253-61. doi: 10.1016/j.echo.2003.11.002.
4
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.收缩功能保留的心力衰竭住院患者的特征、治疗及结局:OPTIMIZE-HF注册研究报告
J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. doi: 10.1016/j.jacc.2007.04.064. Epub 2007 Aug 6.
5
Chronic ambulatory intracardiac pressures and future heart failure events.慢性动态心内压力与未来心力衰竭事件。
Circ Heart Fail. 2010 Sep;3(5):580-7. doi: 10.1161/CIRCHEARTFAILURE.109.923300. Epub 2010 Jun 18.
6
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.植入式连续血流动力学监测仪用于晚期心力衰竭患者的随机对照试验:COMPASS-HF研究
J Am Coll Cardiol. 2008 Mar 18;51(11):1073-9. doi: 10.1016/j.jacc.2007.10.061.
7
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.因心力衰竭恶化且左心室射血分数降低而住院的患者的死亡原因和再住院情况:托伐普坦治疗心力衰竭的疗效和生存研究(EVEREST)项目结果。
Am Heart J. 2010 May;159(5):841-849.e1. doi: 10.1016/j.ahj.2010.02.023.
8
[Prognostic implications of left ventricular end-diastolic pressure in acute coronary syndromes with left ventricular ejection fraction of 40% or over].[左心室舒张末期压力对左心室射血分数40%及以上的急性冠状动脉综合征的预后影响]
Rev Port Cardiol. 2011 Oct;30(10):771-9. doi: 10.1016/S0870-2551(11)70025-7.
9
Usefulness of Noninvasively Measured Pulse Amplitude Changes During the Valsalva Maneuver to Identify Hospitalized Heart Failure Patients at Risk of 30-Day Heart Failure Events (from the PRESSURE-HF Study).在 Valsalva 动作期间无创测量脉搏幅度变化对识别 30 天内心力衰竭事件风险的住院心力衰竭患者的作用(来自 PRESSURE-HF 研究)。
Am J Cardiol. 2020 Mar 15;125(6):916-923. doi: 10.1016/j.amjcard.2019.12.027. Epub 2019 Dec 27.
10
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.N-末端脑利钠肽前体指导的强化患者管理联合多学科治疗对慢性心力衰竭患者的影响:一项 3 臂前瞻性随机对照研究
J Am Coll Cardiol. 2010 Feb 16;55(7):645-53. doi: 10.1016/j.jacc.2009.08.078.

引用本文的文献

1
Combination Diuretic Therapy With Thiazides: A Systematic Review on the Beneficial Approach to Overcome Refractory Fluid Overload in Heart Failure.噻嗪类联合利尿剂治疗:克服心力衰竭难治性液体超负荷的有益方法的系统评价
Cureus. 2023 Sep 3;15(9):e44624. doi: 10.7759/cureus.44624. eCollection 2023 Sep.
2
Three-vessel coronary infusion of cardiosphere-derived cells for the treatment of heart failure with preserved ejection fraction in a pre-clinical pig model.三血管冠状输注心脏球来源细胞治疗射血分数保留心力衰竭的临床前猪模型研究。
Basic Res Cardiol. 2023 Jul 3;118(1):26. doi: 10.1007/s00395-023-00995-2.
3
Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction.
冠状动脉内递送自组装心脏来源的微组织(心肌球)以预防恢复期心肌梗死猪模型中的不良重塑。
Circ Cardiovasc Interv. 2015 May;8(5). doi: 10.1161/CIRCINTERVENTIONS.115.002391.
4
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group.急性心力衰竭患者的早期管理:现状与未来方向——SAEM/HFSA急性心力衰竭工作组的共识文件
Acad Emerg Med. 2015 Jan;22(1):94-112. doi: 10.1111/acem.12538. Epub 2014 Nov 25.
5
Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group.急性心力衰竭患者的早期管理:现状与未来方向。美国学术急诊医学学会/美国心力衰竭学会急性心力衰竭工作组的一份共识文件。
J Card Fail. 2015 Jan;21(1):27-43. doi: 10.1016/j.cardfail.2014.07.003. Epub 2014 Jul 18.
6
The role of the emergency department in the patient with acute heart failure.急诊科在急性心力衰竭患者中的作用。
Curr Cardiol Rep. 2013 Jun;15(6):365. doi: 10.1007/s11886-013-0365-3.
7
Congestion is the driving force behind heart failure.充血是心力衰竭背后的驱动力。
Curr Heart Fail Rep. 2012 Sep;9(3):219-27. doi: 10.1007/s11897-012-0093-9.
8
Finger photoplethysmography during the Valsalva maneuver reflects left ventricular filling pressure.手指光体积描记法在瓦尔萨尔瓦动作期间反映左心室充盈压。
Am J Physiol Heart Circ Physiol. 2012 May 15;302(10):H2043-7. doi: 10.1152/ajpheart.00609.2011. Epub 2012 Mar 2.